Hsu; Margaret Chi-Ping

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hsu; Margaret Chi-Ping.The latest application filed is for "fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor".

Company Profile

0.11.9

Hsu; Margaret Chi-Ping - Lake Forest IL US
Hsu; Margaret Chi-Ping - Vernon Hills IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptors Grant 8,519,186 - Lukin , et al. August 27, 2	2013-08-27
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor Grant 8,487,116 - Gomtsyan , et al. July 16, 2	2013-07-16
Fused Compounds That Inhibit Vanilloid Receptor Subtype 1 (vr1) Receptor App 20120190845 - Gomtsyan; Arthur R. ; et al.	2012-07-26
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor Grant 8,071,762 - Gomtsyan , et al. December 6, 2	2011-12-06
Antagonists Of The Vanilloid Receptor Subtype 1 (vr1) And Use Thereof App 20110144057 - Gomtsyan; Arthur ; et al.	2011-06-16
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof Grant 7,902,236 - Gomtsyan , et al. March 8, 2	2011-03-08
Process For The Preparation Of Indazolyl Ureas That Inhibit Vanilloid Subtype 1 (vr1) Receptors App 20110040102 - Lukin; Kirill A. ; et al.	2011-02-17
Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors Grant 7,847,104 - Lukin , et al. December 7, 2	2010-12-07
Antagonists Of The Vanilloid Receptor Subtype 1 (vr1) And Use Thereof App 20100010055 - Gomtsyan; Arthur ; et al.	2010-01-14
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof Grant 7,504,520 - Gomtsyan , et al. March 17, 2	2009-03-17
Fused Compounds That Inhibit Vanilloid Receptor Subtype 1 (vr1) Receptor App 20080287676 - Gomtsyan; Arthur R. ; et al.	2008-11-20
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor Grant 7,375,126 - Gomtsyan , et al. May 20, 2	2008-05-20
Process for the Preparation of Indazolyl Ureas that Inhibit Vanilloid Subtype1 (VR1) Receptors App 20070244178 - Lukin; Kirill A. ; et al.	2007-10-18
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof App 20060281799 - Gomtsyan; Arthur ; et al.	2006-12-14
Arylation method for the functionalization of O-allyl erythromycin derivatives Grant 7,071,314 - Zhang , et al. July 4, 2	2006-07-04
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor App 20050043351 - Gomtsyan, Arthur R. ; et al.	2005-02-24
Arylation method for the functionalization of O-allyl erythromycin derivatives App 20030125531 - Zhang, Weijang ; et al.	2003-07-03
Process for preparing 6-o-substituted erythromycin derivatives Grant 6,437,106 - Stoner , et al. August 20, 2	2002-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.